Literature DB >> 25605307

Biosynthesis and transport of the lantibiotic mutacin 1140 produced by Streptococcus mutans.

Jerome Escano1, Byron Stauffer1, Jacob Brennan1, Monica Bullock1, Leif Smith2.   

Abstract

UNLABELLED: Lantibiotics are ribosomally synthesized peptide antibiotics composed of an N-terminal leader peptide that is cleaved to yield the active antibacterial peptide. Significant advancements in molecular tools that promote the study of lantibiotic biosynthesis can be used in Streptococcus mutans. Herein, we further our understanding of leader peptide sequence and core peptide structural requirements for the biosynthesis and transport of the lantibiotic mutacin 1140. Our study on mutacin 1140 biosynthesis shows a dedicated secondary cleavage site within the leader peptide and the dependency of transport on core peptide posttranslational modifications (PTMs). The secondary cleavage site on the leader peptide is found at the -9 position, and secondary cleavage occurs before the core peptide is transported out of the cell. The coordinated cleavage at the -9 position was absent in a lanT deletion strain, suggesting that the core peptide interaction with the LanT transporter enables uniform cleavage at the -9 position. Following transport, the LanP protease was found to be tolerant to a wide variety of amino acid substitutions at the primary leader peptide cleavage site, with the exception of arginine at the -1 position. Several leader and core peptide mutations produced core peptide variants that had intermediate stages of PTM enzyme modifications, supporting the concept that PTM enzyme modifications, secondary cleavage, and transport are occurring in a highly coordinated fashion. IMPORTANCE: Mutacin 1140 belongs to the class I lantibiotic family of ribosomally synthesized and posttranslationally modified peptides (RiPPs). The biosynthesis of mutacin 1140 is a highly efficient process which does not lead to a discernible level of production of partially modified core peptide variants. The products isolated from an extensive mutagenesis study on the leader and core peptides of mutacin 1140 show that the posttranslational modifications (PTMs) on the core peptide occur under a highly coordinated dynamic process. PTMs are dictated by the distance of the core peptide modifiable residues from PTM enzyme active sites. The formation of lanthionine rings aids in the formation of successive PTMs, as was observed in a peptide variant lacking a C-terminal decarboxylation.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25605307      PMCID: PMC4352662          DOI: 10.1128/JB.02531-14

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  53 in total

1.  The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics.

Authors:  Shang-Te D Hsu; Eefjan Breukink; Eugene Tischenko; Mandy A G Lutters; Ben de Kruijff; Robert Kaptein; Alexandre M J J Bonvin; Nico A J van Nuland
Journal:  Nat Struct Mol Biol       Date:  2004-09-12       Impact factor: 15.369

2.  Diversity of Streptococcus mutans bacteriocins as confirmed by DNA analysis using specific molecular probes.

Authors:  Sadjia Bekal-Si Ali; Yves Hurtubise; Marc C Lavoie; Gisèle LaPointe
Journal:  Gene       Date:  2002-01-23       Impact factor: 3.688

3.  Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.

Authors:  E Breukink; I Wiedemann; C van Kraaij; O P Kuipers; H G Sahl; B de Kruijff
Journal:  Science       Date:  1999-12-17       Impact factor: 47.728

4.  Effect of amino acid substitutions in conserved residues in the leader peptide on biosynthesis of the lantibiotic mutacin II.

Authors:  P Chen; F X Qi; J Novak; R E Krull; P W Caufield
Journal:  FEMS Microbiol Lett       Date:  2001-02-20       Impact factor: 2.742

5.  Optimization of the Production of the Lantibiotic Mutacin 1140 in Minimal Media.

Authors:  Dahal Neeti; Chaney Noel; Ellis Dayna; Lu Shi-En; Smith Leif
Journal:  Process Biochem       Date:  2010-07-01       Impact factor: 3.757

6.  In vitro reconstitution and substrate specificity of a lantibiotic protease.

Authors:  L A Furgerson Ihnken; Champak Chatterjee; Wilfred A van der Donk
Journal:  Biochemistry       Date:  2008-06-21       Impact factor: 3.162

7.  pKSS--a second-generation general purpose cloning vector for efficient positive selection of recombinant clones.

Authors:  P Kast
Journal:  Gene       Date:  1994-01-28       Impact factor: 3.688

8.  Pep5, a new lantibiotic: structural gene isolation and prepeptide sequence.

Authors:  C Kaletta; K D Entian; R Kellner; G Jung; M Reis; H G Sahl
Journal:  Arch Microbiol       Date:  1989       Impact factor: 2.552

9.  Structure of the nisin leader peptidase NisP revealing a C-terminal autocleavage activity.

Authors:  Yueyang Xu; Xin Li; Ruiqing Li; Shanshan Li; Hongqian Ni; Hui Wang; Haijin Xu; Weihong Zhou; Per E J Saris; Wen Yang; Mingqiang Qiao; Zihe Rao
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-05-23

10.  Elucidation of the antimicrobial mechanism of mutacin 1140.

Authors:  Leif Smith; Hester Hasper; Eefjan Breukink; Jan Novak; Jirí Cerkasov; J D Hillman; Shawanda Wilson-Stanford; Ravi S Orugunty
Journal:  Biochemistry       Date:  2008-02-12       Impact factor: 3.162

View more
  8 in total

Review 1.  Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes.

Authors:  Lindsay M Repka; Jonathan R Chekan; Satish K Nair; Wilfred A van der Donk
Journal:  Chem Rev       Date:  2017-01-30       Impact factor: 60.622

2.  Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery.

Authors:  Jerome Escano; Akshaya Ravichandran; Bita Salamat; Leif Smith
Journal:  Appl Environ Microbiol       Date:  2017-06-30       Impact factor: 4.792

3.  Two Flavoenzymes Catalyze the Post-Translational Generation of 5-Chlorotryptophan and 2-Aminovinyl-Cysteine during NAI-107 Biosynthesis.

Authors:  Manuel A Ortega; Dillon P Cogan; Subha Mukherjee; Neha Garg; Bo Li; Gabrielle N Thibodeaux; Sonia I Maffioli; Stefano Donadio; Margherita Sosio; Jerome Escano; Leif Smith; Satish K Nair; Wilfred A van der Donk
Journal:  ACS Chem Biol       Date:  2017-01-13       Impact factor: 5.100

4.  Substrate Recognition by the Class II Lanthipeptide Synthetase HalM2.

Authors:  Imran R Rahman; Jeella Z Acedo; Xiaoran Roger Liu; Lingyang Zhu; Justine Arrington; Michael L Gross; Wilfred A van der Donk
Journal:  ACS Chem Biol       Date:  2020-04-28       Impact factor: 5.100

5.  Efficacious Analogs of the Lantibiotic Mutacin 1140 against a Systemic Methicillin-Resistant Staphylococcus aureus Infection.

Authors:  Mengxin Geng; Akshaya Ravichandran; Jerome Escano; Leif Smith
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

6.  Modifying the Lantibiotic Mutacin 1140 for Increased Yield, Activity, and Stability.

Authors:  Mengxin Geng; Leif Smith
Journal:  Appl Environ Microbiol       Date:  2018-07-17       Impact factor: 4.792

7.  Proteomic Characterization and Target Identification Against Streptococcus mutans Under Bacitracin Stress Conditions Using LC-MS and Subtractive Proteomics.

Authors:  Sahar Zaidi; Tulika Bhardwaj; Pallavi Somvanshi; Asad U Khan
Journal:  Protein J       Date:  2022-01-06       Impact factor: 4.000

Review 8.  Lanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical production.

Authors:  Elvis Legala Ongey; Peter Neubauer
Journal:  Microb Cell Fact       Date:  2016-06-07       Impact factor: 5.328

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.